Unknown

Dataset Information

0

Accelerating Drug Development through Repurposed FDA-Approved Drugs for COVID-19: Speed Is Important, Not Haste.

ABSTRACT:

SUBMITTER: Gordy JT 

PROVIDER: S-EPMC7526802 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Accelerating Drug Development through Repurposed FDA-Approved Drugs for COVID-19: Speed Is Important, Not Haste.

Gordy James T JT   Mazumdar Kaushiki K   Dutta Noton K NK  

Antimicrobial agents and chemotherapy 20200722 8

Similar Datasets

Unknown Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML.
| S-EPMC9966469 | biostudies-literature
Unknown Accelerating the repurposing of FDA-approved drugs against coronavirus disease-19 (COVID-19).
| S-EPMC9057693 | biostudies-literature
Unknown Computational Insights and Virtual Screening of Repurposed FDA-Approved Drug Against SARS-CoV-2 Protease
| S-EPMC10184101 | biostudies-literature
Unknown Alchemical analysis of FDA approved drugs.
| S-EPMC10561545 | biostudies-literature
Transcriptomics Transcriptome analysis of osteosarcoma cell lines treated with FDA-approved drugs
2025-12-31 | GSE218036 | GEO
Transcriptomics Identification of FDA-Approved Drugs that Induce Heart Regeneration in Mammals
2024-01-19 | GSE240520 | GEO
Unknown Computational prognostic evaluation of Alzheimer's drugs from FDA-approved database through structural conformational dynamics and drug repositioning approaches.
| S-EPMC10590448 | biostudies-literature
Unknown Pharmacogenomic Drug-Target Network Analysis Reveals Similarity Profiles Among FDA-Approved Cancer Drugs.
| S-EPMC12655765 | biostudies-literature
Unknown Synergy testing of FDA-approved drugs identifies potent drug combinations against Trypanosoma cruzi.
| S-EPMC4102417 | biostudies-literature
Unknown Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales.
| S-EPMC8807560 | biostudies-literature